264 related articles for article (PubMed ID: 23046024)
1. New therapeutical strategies in the treatment of metastatic disease.
Julia F; Thomas L; Dalle S
Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
[TBL] [Abstract][Full Text] [Related]
2. New drugs in melanoma: it's a whole new world.
Eggermont AM; Robert C
Eur J Cancer; 2011 Sep; 47(14):2150-7. PubMed ID: 21802280
[TBL] [Abstract][Full Text] [Related]
3. Upcoming strategies for the treatment of metastatic melanoma.
Spagnolo F; Queirolo P
Arch Dermatol Res; 2012 Apr; 304(3):177-84. PubMed ID: 22350184
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of metastatic melanoma: emerging trends and opportunities for a cure.
Pretto F; Neri D
Pharmacol Ther; 2013 Sep; 139(3):405-11. PubMed ID: 23711792
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy in the treatment of advanced or metastatic melanoma: nivolumab from phase I studies to approvement by European Medicines Agency].
Queirolo P; Tanda ET
Recenti Prog Med; 2015 Dec; 106(12):608-17. PubMed ID: 26780070
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on pembrolizumab in the treatment of advanced melanoma.
Rajakulendran T; Adam DN
Drug Des Devel Ther; 2015; 9():2883-6. PubMed ID: 26082618
[TBL] [Abstract][Full Text] [Related]
7. Advances in the management of melanoma: targeted therapy, immunotherapy and future directions.
Dean E; Lorigan P
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1437-48. PubMed ID: 23249108
[TBL] [Abstract][Full Text] [Related]
8. Advances in targeted therapy for unresectable melanoma: new drugs and combinations.
Hao M; Song F; Du X; Wang G; Yang Y; Chen K; Yang J
Cancer Lett; 2015 Apr; 359(1):1-8. PubMed ID: 25578781
[TBL] [Abstract][Full Text] [Related]
9. Successes and setbacks of early investigational drugs for melanoma.
Orloff M; Valsecchi ME; Sato T
Expert Opin Investig Drugs; 2015; 24(8):993-7. PubMed ID: 26068553
[TBL] [Abstract][Full Text] [Related]
10. New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies.
Azijli K; Stelloo E; Peters GJ; VAN DEN Eertwegh AJ
Anticancer Res; 2014 Apr; 34(4):1493-505. PubMed ID: 24692676
[TBL] [Abstract][Full Text] [Related]
11. Ipilimumab approved for metastatic melanoma.
Traynor K
Am J Health Syst Pharm; 2011 May; 68(9):768. PubMed ID: 21515855
[No Abstract] [Full Text] [Related]
12. Targeted therapies in metastatic melanoma: toward a clinical breakthrough?
Julia F; Thomas L; Dumontet C; Dalle S
Anticancer Agents Med Chem; 2010 Nov; 10(9):661-5. PubMed ID: 21235437
[TBL] [Abstract][Full Text] [Related]
13. Targeted molecular therapy in melanoma.
Puzanov I; Flaherty KT
Semin Cutan Med Surg; 2010 Sep; 29(3):196-201. PubMed ID: 21051014
[TBL] [Abstract][Full Text] [Related]
14. A review of novel therapies for melanoma.
Karimkhani C; Gonzalez R; Dellavalle RP
Am J Clin Dermatol; 2014 Aug; 15(4):323-37. PubMed ID: 24928310
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
Kim KB
Cancer; 2013 Feb; 119(3):477-80. PubMed ID: 22915026
[No Abstract] [Full Text] [Related]
16. Treatment algorithms in stage IV melanoma.
Espinosa E; Grob JJ; Dummer R; Rutkowski P; Robert C; Gogas H; Kefford R; Eggermont AM; Martin Algarra S; Hauschild A; Schadendorf D
Am J Ther; 2015; 22(1):61-7. PubMed ID: 24413374
[TBL] [Abstract][Full Text] [Related]
17. Current advances and perspectives in the treatment of advanced melanoma.
Livingstone E; Zimmer L; Vaubel J; Schadendorf D
J Dtsch Dermatol Ges; 2012 May; 10(5):319-25. PubMed ID: 22432863
[TBL] [Abstract][Full Text] [Related]
18. Prospects for non-immunological molecular therapeutics in melanoma.
Eustace AJ; Mahgoub T; Tryfonopoulos D; O'Donovan N; Crown J
J BUON; 2010; 15(1):9-18. PubMed ID: 20414921
[TBL] [Abstract][Full Text] [Related]
19. Challenging resistance mechanisms to therapies for metastatic melanoma.
Tentori L; Lacal PM; Graziani G
Trends Pharmacol Sci; 2013 Dec; 34(12):656-66. PubMed ID: 24210882
[TBL] [Abstract][Full Text] [Related]
20. New therapeutic options in systemic treatment of advanced cutaneous melanoma.
Mackiewicz-Wysocka M; Zolnierek J; Wysocki PJ
Expert Opin Investig Drugs; 2013 Feb; 22(2):181-90. PubMed ID: 23215674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]